Vice President & Associate General Counsel
San Diego, California
(NYSE: CFN) $4.0B Global medical device, drug manufacturer, and service provider for the healthcare industry. 2009 Spin-off from Cardinal Health, Inc. Divisional counsel for $1.2B Medical Technologies and Services segment comprised of five businesses, Infection Prevention (Chlorapreprep® pre-operative skin preparation drug/device combination), V.Mueller/OnSite (V.Mueller® and Snowden Pencer® open and minimally invasive surgical instruments and instrument repair services), Interventional Specialties (AvaMax® and PleurX® interventional radiologists guided medical devices), International Surgical Products (international distributor of surgical gowns, drapes, gloves and fluid management), and Neurocare (Nicolet® neurological and vascular diagnostic medical devices). Executive team member and counsel for President of MTS segment and General Managers of each of the underlying businesses. Direct responsibility for all legal aspects of each business including compliance with FDA (both medical device and drug products), SEC & SOX reporting requirements, patent licensing and product development agreements, supply agreements, contract manufacturing agreements, distribution agreements, sales agreements, GPO agreements, strategic alliances, partnerships, clinical studies, confidentiality agreements and the review of business claims and communications, and press releases. Founder and Chairman of HOLA (Hispanic Organization for Leadership and Awareness) a company sponsored employee affinity group.